1. Andriyanova, A.V., Clinical features and neurohumoral mechanisms of development of manifest heart failure: innovative aspects of diagnostics and secondary prevention measures, Extended Abstract of Cand. Sci. (Med.) Dissertation, Tomsk, 2015.
2. Gorshunova, N.K., Medvedev, N.V., and Savich, V.V., Involute and hypertensive fibrous heart transformation during myocardial dysfunction and circulatory failure, Usp. Gerontol., 2018, vol. 31, no. 1, pp. 132–138.
3. Gyamdzhyan, K.A., Drapkina, O.M., and Maksimov, M.L., Galectin-3: clinical and prognostic role for examination of patients with chronic heart failure, Serdechnaya Nedostatochn., 2014, no. 1, pp. 51–55.
4. Gyamdzhyan, K.A., Kukes, V.G., and Maksimov, M.L., Clinical determination of galectin-3 in patients with chronic heart failure, Med. Sovet, 2017, no. 7, pp. 63–68.
5. Drapkina, O.M. and Kostyukevich, M.V., The effect of renin–angiotensin–aldosterone system blockers on myocardial remodeling and the risk of atrial fibrillation in patients with arterial hypertension, Klinitsist, 2012, nos. 3–4, pp. 73–79.